Erbitux and mucosal inflammation 
Erbitux and mucosal inflammation Patient Reports February 11, 2012
Erbitux Side Effects Report #5252426-4
Erbitux side effect was reported by a Pharmacist from UNITED STATES on Nov 16, 2006. Female patient, 65 years of age, weighting 130.1 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dermatitis acneiform, mucosal inflammation, pyrexia. Erbitux dosage: 100 MG/50 ML. During the same period patient was treated with DYAZIDE, DALMANE, PREMARIN, SYNTHROID. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5120326-6
Erbitux side effect was reported by a Pharmacist from UNITED STATES on Oct 02, 2006. Female patient, 65 years of age, weighting 129.2 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dermatitis acneiform, mucosal inflammation, nasopharyngeal disorder, oesophagitis, pyrexia. Erbitux dosage: unknown. During the same period patient was treated with DYAZUDE, DALMANE, PREMARIN, SYNTHROID. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5161303-9
Erbitux side effect was reported by a Pharmacist from UNITED STATES on Oct 20, 2006. Female patient, 65 years of age, weighting 130.1 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dermatitis acneiform, mucosal inflammation, pyrexia. Erbitux dosage: 100 MG/50 ML. During the same period patient was treated with DYAZIDE, DALMANE, PREMARIN, SYNTHROID. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5213230-6
Erbitux side effect was reported by a Health Professional from UNITED STATES on Jan 18, 2007. Male patient, 51 years of age, weighting 212.1 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: body temperature increased, cough, dehydration, dysphagia, mucosal inflammation, vomiting. Erbitux dosage: 250 MG/M2 ONCE/WEEK IV DRIP. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5213286-0
Erbitux side effect was reported by a Health Professional from UNITED STATES on Jan 18, 2007. Male patient, 51 years of age, weighting 212.1 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: body temperature increased, cough, dehydration, dysphagia, mucosal inflammation, pain
, vomiting. Erbitux dosage: 250 MG/M2 ONCE / WEEK IV DRIP. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5217018-1
Erbitux side effect was reported by a Health Professional from UNITED STATES on Jan 18, 2007. Male patient, 51 years of age, weighting 211.6 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: cough, dehydration, dysphagia, mucosal inflammation, oxygen saturation decreased, pneumonia aspiration, vomiting. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5234323-3
Erbitux side effect was reported by a Health Professional from UNITED STATES on Feb 06, 2007. Male patient, 51 years of age, weighting 211.6 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dehydration, dysphagia, infection
, mucosal inflammation, pneumonia aspiration. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5235530-6
Erbitux side effect was reported by a Health Professional from UNITED STATES on Feb 06, 2007. Male patient, 51 years of age, weighting 211.6 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dehydration, dysphagia, infection
, mucosal inflammation, pneumonia aspiration. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5239494-0
Erbitux side effect was reported by a Health Professional from UNITED STATES on Feb 14, 2007. Male patient, 51 years of age, weighting 198.6 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: cough, dehydration, feeding tube complication, mucosal inflammation, nausea
, saliva altered. Erbitux dosage: 250 MG/M2 ONCE / WEEK IV DRIP. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5242590-5
Erbitux side effect was reported by a Health Professional from UNITED STATES on Feb 13, 2007. Male patient, 51 years of age, weighting 211.6 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: cough, dehydration, dysphagia, infection
, mucosal inflammation, nausea , pneumonia aspiration, saliva altered. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5256642-7
Erbitux side effect was reported by a Health Professional from UNITED STATES on Feb 27, 2007. Male patient, 51 years of age, weighting 211.6 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: cough, dehydration, dysphagia, infection
, mucosal inflammation, nausea , pneumonia aspiration. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5267246-4
Erbitux side effect was reported by a Health Professional from UNITED STATES on Mar 15, 2007. Male patient, 51 years of age, weighting 211.6 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: catheter related infection, cough, dehydration, dysphagia, mucosal inflammation, nausea
, pneumonia aspiration. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5268255-1
Erbitux side effect was reported by a Health Professional from UNITED STATES on Mar 14, 2007. Male patient, 39 years of age, weighting 160.9 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, mucosal inflammation, weight decreased. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN, TAXOTERE, FENTANYL, OXYCODONE, GABAPENTIN, DECADRON, ZOFRAN. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5616503-8
Erbitux side effect was reported by a Health Professional from UNITED STATES on Feb 04, 2008. Female patient, 68 years of age, weighting 163.1 lb, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: haemoglobin decreased, international normalised ratio increased, mucosal inflammation, neutrophil count decreased, platelet count decreased, rash
. Erbitux dosage: 400 MG/M*2 DAY 1, THEN 250 MG/M*2 EVERY 8 DAYS.. During the same period patient was treated with ALIMTA, METOPROLOL TARTRATE, ACYCLOVIR, FENTANYL TRANSDERMAL SYSTEM, FOLIC ACID, LIPITOR, DECADRON. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5082676-1
Erbitux side effect was reported by a Health Professional from UNITED STATES on Aug 14, 2006. Male patient, 64 years of age, weighting 202.8 lb, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: anaemia, dyspnoea, febrile neutropenia, mucosal inflammation, platelet count decreased, pyrexia, renal failure, white blood cell count decreased. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN, CIPROFLOXACIN, CLAVULIN. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5074197-7
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on May 17, 2006. Male patient, 59 years of age, weighting 169.8 lb, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: aspiration, cough, mucosal inflammation, pyrexia, rash
. Erbitux dosage: unknown. During the same period patient was treated with DOCETAXEL, SENOKOT, FLOMAX, ZYRTEC, OXYCODONE. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5008846-6
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on May 17, 2006. Male patient, 59 years of age, weighting 169.8 lb, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: aspiration, cough, mucosal inflammation, pain
, pyrexia, rash . Erbitux dosage: unknown. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5024776-8
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on May 17, 2006. Male patient, 59 years of age, weighting 169.8 lb, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: aspiration, cough, mucosal inflammation, pyrexia, rash
. Erbitux dosage: unknown. During the same period patient was treated with DOCETAXEL, SENOKOT, FLOMAX, ZYRTEC, OXYCODONE. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5031469-X
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on May 17, 2006. Male patient, 59 years of age, weighting 169.8 lb, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: aspiration, cough, mucosal inflammation, pyrexia, rash
. Erbitux dosage: unknown. During the same period patient was treated with DOCETAXEL, SENOKOT, FLOMAX, ZYRTEC, OXYCODONE. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5034062-8
Erbitux side effect was reported by a Health Professional from UNITED STATES on June 09, 2006. Male patient, 58 years of age, weighting 220.5 lb, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, fatigue, insomnia, mucosal inflammation, skin exfoliation. Erbitux dosage: COURSE 6: REC'D 541 MG. START DATE COURSE 1: 09-MAY-06.. During the same period patient was treated with CISPLATIN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5063175-X
Erbitux side effect was reported by a Consumer or non-health professional from GERMANY on Feb 09, 2006. Male patient, 57 years of age, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: mucosal inflammation, neutropenia, thrombocytopenia. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #4978094-4
Erbitux side effect was reported by a Consumer or non-health professional from GERMANY on Nov 08, 2005. Male patient, 57 years of age, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: agranulocytosis, asthenia, azotaemia, cachexia, dehydration, increased upper airway secretion, mucosal inflammation, oral intake reduced, platelet count decreased. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient died on 09/05/2005.
Erbitux Side Effects Report #5001207-5
Erbitux side effect was reported by a Consumer or non-health professional from GERMANY on Feb 09, 2006. Male patient, 57 years of age, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: mucosal inflammation, neutropenia, thrombocytopenia. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5049585-5
Erbitux side effect was reported by a Health Professional from UNITED STATES on July 05, 2006. Female patient, 56 years of age, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: mucosal inflammation, rash
. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient recovered.Erbitux Side Effects Report #5060151-8
Erbitux side effect was reported by a Health Professional from UNITED STATES on July 05, 2006. Female patient, 56 years of age, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dehydration, hypokalaemia, mental status changes, mucosal inflammation, rash
. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5082571-8
Erbitux side effect was reported by a Health Professional from UNITED STATES on July 05, 2006. Female patient, 56 years of age, weighting 119.0 lb, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: angina pectoris, dehydration, hypokalaemia, infection
, mental status changes, mucosal inflammation, rash . Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #4987568-1
Erbitux side effect was reported by a Health Professional from UNITED STATES on Apr 24, 2006. Female patient, 54 years of age, weighting 160.9 lb, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphasia, mucosal inflammation. Erbitux dosage: unknown. During the same period patient was treated with PEMETREXED DI. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #4967398-7
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 24, 2006. Male patient, 48 years of age, weighting 207.2 lb, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dehydration, malnutrition, mucosal inflammation, nausea
, weight decreased. Erbitux dosage: 1ST COURSE = 25-JAN-2006. TOTAL DOSE ADMINISTERED THIS COURSE = 4164 MG.. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5684870-5
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 08, 2007. Male patient, 47 years of age, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: hepatic function abnormal, mucosal inflammation, rash
. Erbitux dosage: unknown. Patient recovered.Erbitux Side Effects Report #5886177-X
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 09, 2008. Male patient, 81 years of age, weighting 183.0 lb, was diagnosed with rectal cancer, depression
and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dehydration, hypotension, mucosal inflammation. Erbitux dosage: unknown. During the same period patient was treated with FLUOROURACIL, CYMBALTA, ASMANEX TWISTHALER, SPIRIVA, SIMVASTATIN, LISINOPRIL. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5896097-2
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 23, 2008. Male patient, 81 years of age, weighting 183.0 lb, was diagnosed with rectal cancer, depression
and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dehydration, hypotension, mucosal inflammation. Erbitux dosage: unknown. During the same period patient was treated with FLUOROURACIL, CYMBALTA, ASMANEX TWISTHALER, SPIRIVA, SIMVASTATIN, LISINOPRIL. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5040855-3
Erbitux side effect was reported by a Physician from UNITED STATES on June 27, 2006. Female patient, 74 years of age, weighting 114.6 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, mucosal inflammation. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5064420-7
Erbitux side effect was reported by a Health Professional from UNITED STATES on June 27, 2006. Female patient, 74 years of age, weighting 114.6 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, mucosal inflammation. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, CISPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5684792-X
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 26, 2007. Male patient, 72 years of age, weighting 194.0 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: anal inflammation, mucosal inflammation. Erbitux dosage: unknown. Patient recovered.
Erbitux Side Effects Report #5702427-4
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 07, 2008. Male patient, 70 years of age, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malnutrition, mucosal inflammation, radiation skin injury, skin exfoliation. Erbitux dosage: FIRST LOADING DOSE = 400MG/M*2 ON 10-DEC-07. TOTAL 4 WEEKLY DOSES. 250MG/M2 / 7D. During the same period patient was treated with METOPROLOL TARTRATE, VICODIN, ETHYOL, DOCUSATE, LANSOPRAZOLE, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5707894-8
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 14, 2008. Male patient, 70 years of age, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: malnutrition, mucosal inflammation, radiation skin injury, skin exfoliation. Erbitux dosage: FIRST LOADING DOSE = 400MG/M*2 ON 10-DEC-07. TOTAL 4 WEEKLY DOSES. 250MG/M2 / 7D. During the same period patient was treated with METOPROLOL TARTRATE, VICODIN, ETHYOL, DOCUSATE, LANSOPRAZOLE, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5019070-5
Erbitux side effect was reported by a Health Professional from UNITED STATES on May 30, 2006. Female patient, 70 years of age, weighting 103.6 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: blood sodium decreased, fatigue, inappropriate antidiuretic hormone secretion, mucosal inflammation. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5252516-6
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 22, 2007. Female patient, 65 years of age, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: mucosal inflammation. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient recovered.
Erbitux Side Effects Report #5489879-2
Erbitux side effect was reported by a Health Professional from UNITED STATES on Oct 17, 2007. Male patient, 59 years of age, weighting 172.0 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, mucosal inflammation, pain
. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN, TAXOL, DECADRON, TYLENOL W, CIPRO. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5091843-2
Erbitux side effect was reported by a Health Professional from UNITED STATES on July 11, 2006. Female patient, 57 years of age, weighting 165.3 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: acne
, chills, dehydration, dysphagia, febrile neutropenia, metastasis, mucosal inflammation, pain , pyrexia. Erbitux dosage: unknown. During the same period patient was treated with ALIMTA, DIOVAN, HYDROCHLOROTHIAZIDE, NORMODYNE, LEXAPRO, PREVACID, MINOCYCLINE, FIORICET. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5036924-4
Erbitux side effect was reported by a Health Professional from UNITED STATES on June 21, 2006. Female patient, 56 years of age, weighting 121.3 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, mucosal inflammation. Erbitux dosage: unknown. During the same period patient was treated with ALIMTA. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5051208-6
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on July 07, 2006. Male patient, 54 years of age, weighting 125.7 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dermatitis acneiform, mucosal inflammation, neisseria infection, pyrexia, stomatitis. Erbitux dosage: unknown. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5082039-9
Erbitux side effect was reported by a Health Professional from UNITED STATES on Aug 04, 2006. Female patient, 52 years of age, weighting 154.3 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: acne
, cystitis, dysphagia, mucosal inflammation, neutropenia. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5566478-5
Erbitux side effect was reported by a Health Professional from UNITED STATES on Dec 14, 2007. Male patient, 49 years of age, weighting 156.5 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, mucosal inflammation. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN, ROXICET, COLACE, SENNA, MAGNESIUM OXIDE, MINOCYCLINE, LIDOCAINE VISCOUS. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5260954-0
Erbitux side effect was reported by a Health Professional from UNITED STATES on Mar 08, 2007. Male patient, 39 years of age, weighting 160.9 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, mucosal inflammation. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5047687-0
Erbitux side effect was reported by a Physician from UNITED STATES on July 06, 2006. Female patient, weighting 120.0 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dermatitis, erythema, glossodynia, haemorrhage, mouth ulceration, mucosal inflammation, necrosis, oral pain, purpura. Erbitux dosage: 392.5 MG WEEKLY IV. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, RADIATION. Patient recovered.
Erbitux Side Effects Report #5062761-0
Erbitux side effect was reported by a Health Professional from UNITED STATES on July 24, 2006. Female patient, weighting 157.6 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dehydration, dysphagia, febrile neutropenia, mucosal inflammation. Erbitux dosage: 493 MG IV/EVERY WEEK. During the same period patient was treated with ALIMTA. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5068135-0
Erbitux side effect was reported by a Health Professional from UNITED STATES on July 21, 2006. Female patient, weighting 114.6 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, mucosal inflammation. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5146832-6
Erbitux side effect was reported by a Health Professional from UNITED STATES on Nov 07, 2006. Male patient, weighting 381.4 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: ill-defined disorder, mucosal inflammation. Erbitux dosage: 500MG IV WEEKLY. During the same period patient was treated with ALIMTA. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5038874-6
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on June 28, 2006. Female patient, weighting 145.0 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, mucosal inflammation, oral intake reduced. Erbitux dosage: 363 MG IV. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5110085-5
Erbitux side effect was reported by a Health Professional from UNITED STATES on Sept 19, 2006. Female patient, 51 years of age, weighting 101.4 lb, was diagnosed with nasopharyngeal cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: asthenia, dysphagia, erythema, fatigue, febrile neutropenia, leukopenia, migraine
, mucosal inflammation, pharyngolaryngeal pain. Erbitux dosage: 250 MG ONCE/WEEK IV DRIP. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5105664-5
Erbitux side effect was reported by a Health Professional from UNITED STATES on Sept 11, 2006. Female patient, 65 years of age, weighting 136.7 lb, was diagnosed with lung cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: diarrhoea, dyspepsia, dysphagia, gastrooesophageal reflux disease, glossitis, glossodynia, mucosal inflammation, oesophageal candidiasis, oesophageal pain. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, DOCETAXEL. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5168840-1
Erbitux side effect was reported by a Health Professional from GERMANY on Nov 27, 2006. Male patient, 57 years of age, was diagnosed with lip and/or oral cavity cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: hepatic cirrhosis, mucosal inflammation, skin toxicity. Erbitux dosage: unknown. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #4981891-2
Erbitux side effect was reported by a Health Professional from UNITED STATES on Apr 24, 2006. Female patient, weighting 162.0 lb, was diagnosed with laryngeal neoplasm, squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphasia, mucosal inflammation. Erbitux dosage: 250 MG/M2 (450 MG) EVERY WEEK IV. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #6131225-5
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2008. Male patient, 80 years of age, was diagnosed with head and neck cancer
and was treated with Erbitux. After drug was administered, patient experienced the following side effects: asthenia, mucosal inflammation, radiation skin injury. Erbitux dosage: WITH THE LOADING DOSE OF 680 MG, WEEKLY DOSE OF 425 MG FOR A TOTAL OF 7 WEEKS.DURATION 2 1/2 MONTHS. Patient recovered.Erbitux Side Effects Report #6131626-5
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 23, 2008. Male patient, 78 years of age, was diagnosed with head and neck cancer
and was treated with Erbitux. After drug was administered, patient experienced the following side effects: blepharitis, dermatitis, mucosal inflammation. Erbitux dosage: 250 MG/M2 WEEKLY.. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5892422-7
Erbitux side effect was reported by a Physician from GERMANY on Sept 18, 2008. Female patient, 75 years of age, was diagnosed with head and neck cancer
and was treated with Erbitux. After drug was administered, patient experienced the following side effects: mucosal inflammation, multi-organ failure, pemphigoid, pneumonia . Erbitux dosage: unknown. Patient was hospitalized. Patient died on 01/01/2008.Erbitux Side Effects Report #5903210-7
Erbitux side effect was reported by a Physician from GERMANY on Sept 29, 2008. Female patient, 75 years of age, was diagnosed with head and neck cancer
and was treated with Erbitux. After drug was administered, patient experienced the following side effects: mucosal inflammation, multi-organ failure, pemphigoid, pneumonia . Erbitux dosage: unknown. Patient was hospitalized. Patient died on 01/01/2008.Erbitux Side Effects Report #6068030-4
Erbitux side effect was reported by a Health Professional from UNITED STATES on Jan 30, 2009. Male patient, 63 years of age, weighting 165.3 lb, was diagnosed with head and neck cancer
and was treated with Erbitux. After drug was administered, patient experienced the following side effects: lymphopenia, mucosal inflammation, oral pain, white blood cell disorder. Erbitux dosage: 1STDOSE:08DEC2008.400MG/M2 IV LOADING DOSE FOLLD BY WKS 1-7,250MG/M2IV.DOSE DELYD DUE TO MUCOSITIS.. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5964546-7
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 19, 2008. Male patient, 60 years of age, weighting 141.1 lb, was diagnosed with head and neck cancer
and was treated with Erbitux. After drug was administered, patient experienced the following side effects: febrile neutropenia, mucosal inflammation, pain , rash . Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #6125889-X
Erbitux side effect was reported by a Physician from GERMANY on Mar 13, 2009. Male patient, 56 years of age, weighting 130.1 lb, was diagnosed with head and neck cancer
, epilepsy , analgesia, prophylaxis and was treated with Erbitux. After drug was administered, patient experienced the following side effects: hepatic failure, mucosal inflammation, myocarditis, renal failure. Erbitux dosage: 400 MG/M2 1 IN 1 ONCE ON 28JAN09+ 250 MG/M2 FROM 04FEB-25FEB09(MOST RECENT INFUSION)(DURN-21DAYS). During the same period patient was treated with VALPROIC ACID, FENTANYL, IBUPROFEN, DIPYRONE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #6076556-2
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 09, 2009. Male patient, 51 years of age, weighting 207.2 lb, was diagnosed with head and neck cancer
and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dizziness , haemolytic anaemia, hyperglycaemia, hypokalaemia, hypomagnesaemia, infection , leukopenia, mucosal inflammation, rash . Erbitux dosage: CETUXIMAB400MG/M2 INITIAL250MG/M2 1-7. During the same period patient was treated with CISPLATIN, FENTANYL, STEROIDS. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #4594730-9
Erbitux side effect was reported by a Health Professional from on Jan 28, 2005. Male patient, 69 years of age, weighting 77.16 lb, was diagnosed with colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: cheilitis, dermatitis acneiform, mucosal inflammation. Erbitux dosage: unknown. During the same period patient was treated with ATIVAN, CAMPTOSAR, CELEBREX, COMPAZINE, DURAGESIC PATCH, IMODIUM, LOMOTIL. Patient recovered.
Erbitux Side Effects Report #4675690-9
Erbitux side effect was reported by a Health Professional from on Jan 28, 2005. Male patient, 69 years of age, weighting 77.16 lb, was diagnosed with colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: cheilitis, dermatitis acneiform, mucosal inflammation. Erbitux dosage: unknown. During the same period patient was treated with ATIVAN, CAMPTOSAR, CELEBREX, COMPAZINE, DURAGESIC, IMODIUM, LOMOTIL. Patient recovered.
Erbitux Side Effects Report #5405167-4
Erbitux side effect was reported by a Health Professional from GERMANY on July 25, 2007. Male patient, 62 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: diarrhoea, mucosal inflammation, peritonitis. Erbitux dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #4755828-5
Erbitux side effect was reported by a Health Professional from UNITED STATES on Apr 15, 2005. Female patient, 50 years of age, weighting 189.6 lb, was diagnosed with colorectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: mucosal inflammation. Erbitux dosage: unknown. During the same period patient was treated with BENADRYL, DECADRON, PEPCID, CALCIUM GLUCONATE, CAMPTOSAR, CLIMARA, COUMADIN, ESTROGEN. Patient recovered.
Erbitux Side Effects Report #4931641-0
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 02, 2005. Female patient, 59 years of age, was diagnosed with colon cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: mucosal inflammation. Erbitux dosage: unknown. During the same period patient was treated with FOLINIC ACID, FLUOROURACIL, IRINOTECAN, VITAMINS. Patient recovered.
Erbitux Side Effects Report #4563764-2
Erbitux side effect was reported by a Physician from on Jan 17, 2005. Female patient, 33 years of age, was diagnosed with colon cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: mucosal inflammation. Erbitux dosage: unknown. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, IRINOTECAN. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5684648-2
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on May 24, 2007. Female patient, 64 years of age, was diagnosed with colon cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: anal fistula, diarrhoea, dizziness
, genital rash, mucosal inflammation, tachycardia, vaginal candidiasis, vaginal discharge, vulvovaginal discomfort. Erbitux dosage: unknown. During the same period patient was treated with XELODA, OXALIPLATIN, ALOXI, BENADRYL, DECADRON, TAGAMET. Patient recovered.Erbitux Side Effects Report #5684809-2
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 04, 2007. Male patient, 87 years of age, was treated with Erbitux. After drug was administered, patient experienced the following side effects: mucosal inflammation, oral mucosal erythema, radiation skin injury. Erbitux dosage: unknown. Patient recovered.
Erbitux Side Effects Report #5722959-2
Erbitux side effect was reported by a Physician from GERMANY on Apr 23, 2008. Female patient, 75 years of age, was treated with Erbitux. After drug was administered, patient experienced the following side effects: mucosal inflammation, multi-organ failure, pemphigoid, pneumonia
. Erbitux dosage: unknown. Patient was hospitalized. Patient died on 01/01/2008.Erbitux Side Effects Report #5523761-7
Erbitux side effect was reported by a Health Professional from UNITED STATES on Nov 15, 2007. Female patient, 73 years of age, weighting 127.9 lb, was treated with Erbitux. After drug was administered, patient experienced the following side effects: anxiety
, mucosal inflammation, oral pain, pyrexia, rash . Erbitux dosage: unknown. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5532261-X
Erbitux side effect was reported by a Health Professional from UNITED STATES on Nov 30, 2007. Female patient, 73 years of age, weighting 123.5 lb, was treated with Erbitux. After drug was administered, patient experienced the following side effects: anaemia, cellulitis
, hypocalcaemia, local swelling, mucosal inflammation, neoplasm progression, oedema, parotid gland enlargement, swelling face. Erbitux dosage: 306 MG WKLY IV. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5536121-X
Erbitux side effect was reported by a Health Professional from UNITED STATES on Nov 29, 2007. Female patient, 73 years of age, weighting 123.5 lb, was treated with Erbitux. After drug was administered, patient experienced the following side effects: anaemia, anxiety
, blood calcium decreased, localised oedema, mucosal inflammation, oral pain, pyrexia, rash . Erbitux dosage: unknown. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5599702-3
Erbitux side effect was reported by a Health Professional from UNITED STATES on Jan 14, 2008. Female patient, 73 years of age, weighting 127.9 lb, was treated with Erbitux. After drug was administered, patient experienced the following side effects: anaemia, anxiety
, blood calcium decreased, diarrhoea, infection , localised oedema, mucosal inflammation, nausea , oral pain. Erbitux dosage: 250 MG/M2 WEEKLY FROM 19SEP07 TO 01OCT07.. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Erbitux Side Effects Report #5051085-3
Erbitux side effect was reported by a Health Professional from GERMANY on May 15, 2006. Female patient, 69 years of age, was treated with Erbitux. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, granulocytopenia, mucosal inflammation, thrombocytopenia. Erbitux dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient died on 08/23/2005.
Erbitux Side Effects Report #5809860-0
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on July 03, 2008. Male patient, 68 years of age, weighting 229.3 lb, was treated with Erbitux. After drug was administered, patient experienced the following side effects: mucosal inflammation. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #4906182-7
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 02, 2006. Male patient, 65 years of age, weighting 149.9 lb, was treated with Erbitux. After drug was administered, patient experienced the following side effects: erythema, face oedema, mucosal inflammation. Erbitux dosage: unknown. During the same period patient was treated with ALOXI, BENADRYL, DECADRON SRC, PERCOCET. Patient recovered.
Erbitux Side Effects Report #5104451-1
Erbitux side effect was reported by a Physician from UNITED STATES on Sept 08, 2006. Female patient, 50 years of age, was treated with Erbitux. After drug was administered, patient experienced the following side effects: alopecia, hirsutism, mucosal inflammation, rash
. Erbitux dosage: LOADING DOSE: 450 MG/M2. During the same period patient was treated with CARBOPLATIN, TAXOL, DEXAMETHASONE, BENADRYL, TAGAMET, EFFEXOR, SYNTHROID. Patient recovered.Erbitux Side Effects Report #5124952-X
Erbitux side effect was reported by a Physician from UNITED STATES on Sept 04, 2006. Female patient, 50 years of age, was treated with Erbitux. After drug was administered, patient experienced the following side effects: alopecia, hirsutism, mucosal inflammation, rash
. Erbitux dosage: LOADING DOSE: 450 MG/M2. During the same period patient was treated with CARBOPLATIN, TAXOL, DEXAMETHASONE, BENADRYL, TAGAMET, EFFEXOR, SYNTHROID. Patient recovered.Erbitux Side Effects Report #5062554-4
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2006. Male patient was treated with Erbitux. After drug was administered, patient experienced the following side effects: laryngeal oedema, mucosal inflammation. Erbitux dosage: 100 MG/50 ML. Patient recovered.
Erbitux Side Effects Report #4771603-X
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 13, 2005. Male patient, weighting 141.1 lb, was treated with Erbitux. After drug was administered, patient experienced the following side effects: dehydration, mucosal inflammation, stomatitis. Erbitux dosage: unknown. During the same period patient was treated with CETUXIMAB, CISPLATIN, RADIATION. Patient was hospitalized. Patient recovered.